AU Patent

AU2012312515A1 — Combination treatments comprising c-met antagonists and B-raf antagonists

Assigned to Genentech Inc · Expires 2014-03-13 · 12y expired

What this patent protects

The present invention relates generally to the fields of molecular biology and growth factor regulation. More specifically, the invention relates to therapies for the treatment of pathological conditions, such as cancer.

USPTO Abstract

The present invention relates generally to the fields of molecular biology and growth factor regulation. More specifically, the invention relates to therapies for the treatment of pathological conditions, such as cancer.

Drugs covered by this patent

Patent Metadata

Patent number
AU2012312515A1
Jurisdiction
AU
Classification
—
Expires
2014-03-13
Drug substance claim
No
Drug product claim
No
Assignee
Genentech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.